BriaCell ($BCTX) expands its Phase 3 footprint:
Penn Medicine’s Abramson Cancer Center joins the Bria-ABC trial in metastatic breast cancer.
• Bria-IMT + checkpoint inhibitor • OS primary endpoint • FDA Fast Track
???? https://bit.ly/3PCPxxi
#biotech #healthcare $LLY $JNJ $PFE